CompoAtlas

SEMULVIT D

Natural health product licensed in Canada

Licence holder
PHARCON Inc.
NPN or DIN-HM
80075088
Status
Active licence
Licence date
17 January 2017
Revision date
Not provided
Form
Liquide
Route of administration
Orale
Application type
Officinale

If this product were sold in France

No point flagged by the rules we apply.

A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.

Composition

Medicinal ingredient and sourcePer dosage unit, according to the sourceMaximum per day, adult
Vitamine D

Source : Cholécalciférol

25 microgrammesNot calculated

Non-medicinal ingredients

Polysorbate 60, d-alpha tocopheryl acetate, PEG-40 Hydrogenated Castor Oil, Huile de coco fractionnée, BHT, Huile essentielle de menthe poivrée, Lécithine, d-alpha-tocopheryl succinate, dl-alpha tocophérol

PopulationAgeQuantity per servingFrequency
AdultesNot specified1 Goutte(s)1 Tous les jours

Uses authorised in Canada

Text supplied in English because no French text is available.

A factor in the maintenance of a good health; Helps to prevent a vitamin D deficiency; Helps in the absorption and use of calcium; Helps in the development and the maintenance of bones; Helps in the development and maintenance of teeth; Calcium intake, when combined with sufficient Vitamin D, a healthy diet and regular exercise may reduce the risk of developing osteoporosis

A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.

Warnings in Canada

No French warning text available in the imported data.

Source

Official Health Canada record, licence 80075088

Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.

Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)

Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)

The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.

The evidence date of this ingredient list is unknown.

Has the product changed? Photograph the packaging.

Enter to analyse, Shift+Enter for a new line